Drug Database
Back to search

Poland· PL-100482203

Sotyktu

A deucravacitinib product containing deucravacitinibum, registered in Poland by Bristol-Myers Squibb Pharma EEIG. The same ATC class is registered in 12 of our 19 countries.

ATC L04AF07

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedSotyktuATCL04AF07REGISTER NO.PL-100482203PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about deucravacitinibumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Deucravacitinib is registered in 12 of 19 countries.

Countries holding a registration under ATC L04AF07 (deucravacitinib), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose
Search deucravacitinib products by name

Deucravacitinib · ATC L04AF07

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of deucravacitinib costs, country by country.

Normalised to the WHO defined daily dose (6 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Deucravacitinib · price per daily dose (6 mg)

USD · FX 28 Sept 2026

  • FR France$22.97
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Deucravacitinibum
Manufacturer
Bristol-Myers Squibb Pharma EEIG
Country
Poland (PL)
ATC code
L04AF07
ATC class
Deucravacitinib
Defined daily dose
6 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    08027950800810

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Deucravacitinib in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All deucravacitinib products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Sotyktu
  • Liechtenstein · Sotyktu
  • Norway · Sotyktu

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2c530e99-bf22-4158-9c87-e676a9b30bb5
GET /v1/drugs/2c530e99-bf22-4158-9c87-e676a9b30bb5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "6 mg",
  "packaging": "Rpz ¦ EU/1/23/1718/004 ¦ 149834\n14 tabl. (w blistrze z kalendarzem)\nRpz ¦ EU/1/23/1718/007 ¦ 149835\n84 tabl. (w blistrze bez kalendarza)\nRpz ¦ EU/1/23/1718/003 ¦ 149836\n14 tabl. (w blistrze bez kalendarza)\nRpz ¦ EU/1/23/1718/002 ¦ 149837\n7 tabl. (w blistrze z kalendarzem)\nRpz ¦ EU/1/23/1718/005 ¦ 149838\n28 tabl. (w blistrze bez kalendarza)\nRpz ¦ EU/1/23/1718/008 ¦ 149839\n84 tabl. (w blistrze z kalendarzem)\nRpz ¦ EU/1/23/1718/001 ¦ 149840\n7 tabl. (w blistrze bez kalendarza)\n08027950800810 ¦ Rpz ¦ EU/1/23/1718/006 ¦ 149841\n28 tabl. (w blistrze z kalendarzem)",
  "substance": "Deucravacitinibum 6 mg",
  "common_name": "Deucravacitinibum",
  "pl_product_id": "100482203",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}
API referenceMCP serverPlans

See everything about deucravacitinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console